CNC — Centene Corporation
Healthcare · ETF XLV · as of 2026-09-18
Daily · EMA 10 / 20 / 50 · SMA 200 · VolPress: buy/sell split, 20-SMA, white dot = above avg · · E = earnings · RS vs SPY ⓘ · ● RS new high ⓘ
Centene Corporation
NYQ
Healthcare · Healthcare Plans
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicar...
Price & today
$65.11
ATR(14) 2.47 (3.80%)
| Stock today | -2.97% |
| Sector ETF today | -0.25% |
| Residual (stock-specific) | -2.72% |
Sector correlation
| 20-day correlation with XLV | 0.63 |
| 60-day correlation with XLV | 0.21 |
| Status | normal |
Decoupling fires when 60d corr − 20d corr > 0.20: stock used to track its sector but the relationship has weakened recently.
Technicals
| 10 EMA | $66.32 |
| 20 EMA | $66.06 |
| 50 EMA | $64.88 |
| EMA stack | BULLISH |
| RSI(14) | 47.8 |
| 52-week high distance | -6.13% |
| 52-week low distance | +158.07% |
Signals
| Market F&G | 46.9 |
| Bull% | 12.2% |
| OVTLYR status | SELL (18d) |
| Sector rank | #450 |
| Next earnings | 2026-10-27 (BMO, 38d) |
MarketSmith metrics - our compute
RS Rating
71.8
ADR%
3.2
RMV (tight)
63.0
Ext (ATR>20EMA)
-0.4
Rel Vol
292.0%
U/D 50d
0.79
U/D 25d
0.75
Accum/Dist 25d
3 / 3
EPS YoY
+1669.0%
LoD dist
3.0
Off 52w High
6.5%
Above 52w Low
105.8%
1W / 1M
-2.0 / +0.6
Avg $Vol 50d
300.3M
Mkt Cap (B)
32.2
Trend 8/8
YES
Leads Group
YES
Sector XLV
+1.8% 1W
Base len (VCP)
10wk (6/18)
Coil (base shape)
85TVPX
What do these abbreviations mean?
- RS Rating
- - IBD-style relative strength vs SPY (weighted 3/6/9/12-mo). 70+ = leaders pool, 80+ = strong.
- ADR%
- - average daily range over 20 days. 4%+ = the fast movers the playbook prefers (selection order, not a gate).
- RMV (tight)
- - Relative Measured Volatility, 15 bars, scaled 0-100. <15 = tight coiled base (green), <35 moderate, high = loose/expanding - not a base right now.
- Ext (ATR>20EMA)
- - how many ATRs price sits above its 20-EMA. ≤1 = in value (green), >2 = extended/chasing (red) - prefer a pullback.
- Rel Vol
- - latest volume vs the 50-day average. 100% = normal; 140%+ = breakout confirmation.
- U/D 50d / 25d
- - up-day vs down-day volume over the window. 1.1+ = net accumulation (institutions buying); under 0.9 on the 25d = net selling.
- Accum/Dist 25d
- - heavy-volume up days vs heavy-volume down days in the last 25 sessions (close moved 0.2%+ on above-average volume). The institutional-participation footprint; 5+ distribution days = O'Neil caution line.
- LoD dist
- - close distance above the day low in % of ATR (100 = one full ATR off the low). High = strong close.
- Off/Above 52w
- - trend-template legs: within 25% of the 52-week high, at least 25% above the 52-week low.
- Trend 8/8
- - all 8 Minervini Trend Template criteria pass. Discovery floor, NOT an entry signal - entries come from the VCP pivot.
- Base len (VCP)
- - weeks since the VCP base started on the latest scan. 10wk+ bases carry the edge; short stacked bases test below random.
Fundamentals & valuation - reference, not entry inputs
P/E (TTM)
-
Fwd P/E
12.4
PEG
1.2
Price/Book
1.4
Profit margin
-2.8%
ROE
-20.4%
Debt/Equity
71.1
Rev growth
+4.6%
Analyst target
$72 (+10%)
Analyst rating
BUY
Institutional %
101.7%
Insider %
0.4%
Float %
91.6%
Valuation and analyst figures are Yahoo company stats (weekly refresh, ~3,000 larger names - blanks are honest gaps); logo, employees, website and IPO date are Massive company reference. Momentum/VCP entries do not use valuation - this card is context so you do not have to leave the page.
Company data - context read, not entry inputs
Industry rank
86 / 147
Industry
Healthcare Plans
Float
452.1M
Float turnover 20d
1.0%
Avg $Vol 20d / 50d
306.2M / 300.3M
Days to cover
2.6
Short % float
3.1%
Institutional %
101.7%
Weinstein stage
2
Float, short interest and institutional % come from Yahoo company stats, refreshed weekly for ~3,000 larger names - a blank means Yahoo does not publish the figure for this stock, not that it is zero. Dollar volume and float turnover are computed from our own price bars; industry rank from our rotation data; stage from the weekly chart.
Quarterly EPS - earnings acceleration
A dash in %Chg is deliberate: the year-ago figure was a loss, so a growth % would be meaningless. A dash in Sales means we have no revenue figure for that quarter - read it as a gap in our data, not as zero revenue.
| Quarter | EPS ($) | %Chg YoY | Sales ($M) | %Chg |
|---|---|---|---|---|
| Oct-24 | 1.62 | -19% | 42,023.0 | +10% |
| Feb-25 | 0.80 | +78% | 40,805.0 | +3% |
| Apr-25 | 2.90 | +28% | 46,620.0 | +15% |
| Jul-25 | -0.16 | -107% | 48,742.0 | +22% |
| Oct-25 | 0.50 | -69% | 49,690.0 | +18% |
| Feb-26 | -1.19 | -249% | 49,725.0 | +22% |
| Apr-26 | 3.37 | +16% | 49,944.0 | +7% |
| Jul-26 | 2.51 | - | 53,579.0 | +10% |
† = SEC carries this same fiscal quarter under a second period-end with a materially different figure (hover for it) - a restatement, merger recast or successor-period split; %Chg is blanked when the two are more than 15% apart. It fires only when the two period-ends DISAGREE, so it is a floor, not a guarantee that the rest of the column shares one basis · ‡ = the revenue concept changed from the previous quarter WITH A FIGURE (hover for both) - a blank row in between is skipped, as the eye does - a step at that row is a change of basis, not necessarily of business · EPS = Yahoo
eps_actual (the figure MarketSmith/Deepvue show) - whether a given quarter is GAAP or excludes a one-off follows the filing, so it can sit either side of another vendor's number; AAPL's Oct-24 row, the Sep-2024 fiscal quarter, is $0.97 here - GAAP, including the EU tax charge - where TradingView's year implies $1.64 · Sales ($M) = SEC EDGAR quarterly revenue (fiscal Q4 derived as FY minus 9-mo) · quarter = report month · %Chg blank = prior-year base under $0.05 (not meaningful).Recent news - our DB (Finnhub + OVTLYR)
- Sep 17 + Can Centene Sustain Its Turnaround Amid Membership Pressure? Zacks Investment Research
- Sep 17 + 4 Value Stocks to Buy as Fed Rate Hikes Test Wall Street Zacks Investment Research
- Sep 17 + Can Centene Sustain Its Turnaround Amid Membership Pressure? Zacks Investment Research
- Sep 17 · 4 Value Stocks to Buy as Fed Rate Hikes Test Wall Street Yahoo
- Sep 16 · Centene Corporation (CNC) Presents at Deutsche Bank 2026 Healthcare Summit Transcript Seeking Alpha
- Sep 16 + Oscar Health vs. Centene: Which ACA Insurer Is the Better Buy? Zacks Investment Research
- Sep 16 · Centene Corporation (CNC) Presents at Deutsche Bank 2026 Healthcare Summit Transcript SeekingAlpha
- Sep 16 · Oscar Health vs. Centene: Which ACA Insurer Is the Better Buy? Yahoo